ERBB2 and breast cancer: BC is a heterogeneous disease, which comprises three major different histological subtypes, defined based on the expression of hormone receptors (oestrogen receptor alpha (ER) and progesterone receptor (PR)), and epidermal growth factor receptor 2 (HER2) [3,4].